-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: January 2012
BIO Applauds Boulder County Decision
After much debate, Boulder County commissioners sided with science and voted to allow some biotech crops to be grown on county-owned land. Six farmers leasing the county land came forward in December 2008 seeking permission to plant herbicide tolerant sugarbeets. After more than two years of hearings, protests, studies, and debates, policy that includes a decision on GMOs was approved. “With our adoption of the Boulder County Cropland Policy on Dec. 20 we believe we Read More >
IBM’s Watson: From Jeopardy! to Drug Research
Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available to corporate clients. The cloud-based Strategic Intellectual Property Insight Platform “uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.” As a byproduct of this project, I.B.M. is contributing their research to the searchable NIH chemical database, which will ease access to information previously Read More >
Maryland Awards $1 Million to Five Biotech Small Businesses
In effort to spur commercialization and advance treatments for cancer and other diseases, the Maryland Biotechnology Center (MBC) announced earlier this month that it awarded a total of $1 million to five promising life sciences companies through its Biotechnology Commercialization Awards and Translational Research awards. The companies, which received up to $200,000 each, will use the funding to advance cancer therapies, ensure food safety, more quickly detect infectious disease and develop more efficient cardiac repair. Read More >
